Estimated Manipulation of Tablets and Capsules to Meet Dose Requirements for Chinese Children: A Cross-Sectional

Liwen Zhang1, Yan Hu2, Panpan Pan1

  • 1Department of Pharmacy, The Children's Hospital, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, China.

Frontiers in Pediatrics
|November 15, 2021
PubMed

Insights

Over 20% of pediatric tablet and capsule prescriptions require manipulation, with a significant portion being avoidable or inappropriate. Availability of lower-strength medications could reduce these manipulations.

Area of Science:

  • Pediatric Pharmacology
  • Pharmaceutical Sciences
  • Drug Formulation

Background:

  • Medication manipulation, including splitting tablets or opening capsules, is common in pediatric care.
  • Dosage adjustments are often necessary for children due to weight-based dosing and limited availability of pediatric formulations.
  • The practice of manipulation can impact drug efficacy and safety, especially for certain medications.

Purpose of the Study:

  • To determine the frequency of tablet and capsule manipulation for pediatric prescriptions in a Chinese hospital.
  • To evaluate the potential reduction in manipulation with the availability of lower-strength drug formulations.
  • To identify the rates of avoidable and inappropriate medication manipulations.

Main Methods:

  • A 1-month prospective study collected data on all prescribed tablets and capsules for children.
  • Manipulation was defined as using only a portion of an intact dosage form.
  • Avoidable and inappropriate manipulations were categorized based on dose rounding, alternative formulations, and contraindications.

Main Results:

  • 17,123 of 78,366 pediatric prescriptions (21.9%) required manipulation.
  • Common manipulations included halving, quartering, and trisecting dosage forms.
  • 19% of manipulations were avoidable, and 19% involved medications with contraindications for manipulation.
  • 21% of manipulations could have been avoided if lower-strength formulations were available.

Conclusions:

  • A high incidence of medication manipulation, including avoidable and inappropriate practices, is observed in pediatric prescriptions.
  • The availability of lower-strength formulations licensed by the Chinese National Medical Products Administration (CNMPA) could significantly reduce medication manipulation.
  • Optimizing drug availability and formulation options is crucial for improving pediatric medication safety.

Related Concept Videos

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
15
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
35
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
22
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
31
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
22